Con: StiflessmallercompetitorsEdwardsLifesciencesCon: Canlimitinnovation (ifmonopolized)Con:Raisescost forconsumersPro:ImprovespatientoutcomesJenaValveCon: Riskof marketmonopolyID&E:Opportunityto designfor inclusionPro:Createscompetitiveadvantage✅Pro:ExpandstreatmentoptionsHeartWareTAVR-ARdevice✅Pro:Promotesfasterdevelopment“CaseStudyMentioned”Pro:EncouragesefficiencyCon:Potential jobloss insmaller firms🌎ID&E:Could createglobaldisparitiesID&E:Increasesaccess tolife-savingdevicesPro:PromotesfasterdevelopmentThoratecID&E:Regulatoryoversightprotectsfairness❌Con:StiflessmallercompetitorsCon:Reducescompetition🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:ImprovespatientoutcomesPro:Drivesinnovation❌Con:Reducescompetition❌Con:Antitrustchallenges🌎ID&E:Regulatoryoversightprotectsfairness🌎ID&E:Risk of biasintechnologyadoption✅Pro:Createscompetitiveadvantage❌Con:Risk ofmarketmonopolyPro:ExpandstreatmentoptionsID&E: Riskof bias intechnologyadoptionPro:Lowerslong-termcostsID&E: Couldcreateglobaldisparities“Innovation”❌Con:Raisescost forconsumers🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Increasesaccess tolife-savingdevicesID&E:Impactsaffordabilityforunderservedpopulations“Innovation”“Antitrust”ID&E: Mayreduceequitableaccess ifcosts rise✅Pro:Lowerslong-termcosts“CaseStudyMentioned”❌Con: Canlimitinnovation (ifmonopolized)❌Con:Potential jobloss insmaller firms✅Pro:Drivesinnovation✅Pro:EncouragesefficiencyCon:Antitrustchallenges🌎ID&E:Opportunityto designfor inclusion“Antitrust”Con: StiflessmallercompetitorsEdwardsLifesciencesCon: Canlimitinnovation (ifmonopolized)Con:Raisescost forconsumersPro:ImprovespatientoutcomesJenaValveCon: Riskof marketmonopolyID&E:Opportunityto designfor inclusionPro:Createscompetitiveadvantage✅Pro:ExpandstreatmentoptionsHeartWareTAVR-ARdevice✅Pro:Promotesfasterdevelopment“CaseStudyMentioned”Pro:EncouragesefficiencyCon:Potential jobloss insmaller firms🌎ID&E:Could createglobaldisparitiesID&E:Increasesaccess tolife-savingdevicesPro:PromotesfasterdevelopmentThoratecID&E:Regulatoryoversightprotectsfairness❌Con:StiflessmallercompetitorsCon:Reducescompetition🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:ImprovespatientoutcomesPro:Drivesinnovation❌Con:Reducescompetition❌Con:Antitrustchallenges🌎ID&E:Regulatoryoversightprotectsfairness🌎ID&E:Risk of biasintechnologyadoption✅Pro:Createscompetitiveadvantage❌Con:Risk ofmarketmonopolyPro:ExpandstreatmentoptionsID&E: Riskof bias intechnologyadoptionPro:Lowerslong-termcostsID&E: Couldcreateglobaldisparities“Innovation”❌Con:Raisescost forconsumers🌎ID&E:Impactsaffordability forunderservedpopulations🌎ID&E:Increasesaccess tolife-savingdevicesID&E:Impactsaffordabilityforunderservedpopulations“Innovation”“Antitrust”ID&E: Mayreduceequitableaccess ifcosts rise✅Pro:Lowerslong-termcosts“CaseStudyMentioned”❌Con: Canlimitinnovation (ifmonopolized)❌Con:Potential jobloss insmaller firms✅Pro:Drivesinnovation✅Pro:EncouragesefficiencyCon:Antitrustchallenges🌎ID&E:Opportunityto designfor inclusion“Antitrust”

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Con: Stifles smaller competitors
  2. Edwards Lifesciences
  3. Con: Can limit innovation (if monopolized)
  4. Con: Raises cost for consumers
  5. Pro: Improves patient outcomes
  6. JenaValve
  7. Con: Risk of market monopoly
  8. ID&E: Opportunity to design for inclusion
  9. Pro: Creates competitive advantage
  10. ✅Pro: Expands treatment options
  11. HeartWare
  12. TAVR-AR device
  13. ✅Pro: Promotes faster development
  14. “Case Study Mentioned”
  15. Pro: Encourages efficiency
  16. Con: Potential job loss in smaller firms
  17. 🌎ID&E: Could create global disparities
  18. ID&E: Increases access to life-saving devices
  19. Pro: Promotes faster development
  20. Thoratec
  21. ID&E: Regulatory oversight protects fairness
  22. ❌Con: Stifles smaller competitors
  23. Con: Reduces competition
  24. 🌎ID&E: May reduce equitable access if costs rise
  25. ✅Pro: Improves patient outcomes
  26. Pro: Drives innovation
  27. ❌Con: Reduces competition
  28. ❌Con: Antitrust challenges
  29. 🌎ID&E: Regulatory oversight protects fairness
  30. 🌎ID&E: Risk of bias in technology adoption
  31. ✅Pro: Creates competitive advantage
  32. ❌Con: Risk of market monopoly
  33. Pro: Expands treatment options
  34. ID&E: Risk of bias in technology adoption
  35. Pro: Lowers long-term costs
  36. ID&E: Could create global disparities
  37. “Innovation”
  38. ❌Con: Raises cost for consumers
  39. 🌎ID&E:Impacts affordability for underserved populations
  40. 🌎ID&E: Increases access to life-saving devices
  41. ID&E:Impacts affordability for underserved populations
  42. “Innovation”
  43. “Antitrust”
  44. ID&E: May reduce equitable access if costs rise
  45. ✅Pro: Lowers long-term costs
  46. “Case Study Mentioned”
  47. ❌Con: Can limit innovation (if monopolized)
  48. ❌Con: Potential job loss in smaller firms
  49. ✅Pro: Drives innovation
  50. ✅Pro: Encourages efficiency
  51. Con: Antitrust challenges
  52. 🌎ID&E: Opportunity to design for inclusion
  53. “Antitrust”